Efficacy News and Research

RSS

Novel Gene-Editing Strategy Harnesses Unusual Protective Ability to Eliminate HIV-1 Infection

Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses.

22 May 2023

Research Details the Food Safety Profile of Genetically Edited Allergen-Free Eggs

Researchers have developed a chicken egg that may be safe for people with egg white allergies. Chicken egg allergies are one of the most common allergies in children.

18 May 2023

Gut Microbiota Interspecies Interactions may Impact the Efficacy of Antibiotics Against C. Difficile

Clostridioides difficile (C. difficile) is a bacterium that can infect the large intestine, with symptoms ranging from diarrhea to life-threatening colon damage.

12 May 2023

Scientists Engineer the First CRISPR-Based Drug Candidate to Directly Target E. Coli

Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant.

10 May 2023

Attaching Microbubbles to Macrophages can Create Tracking Images for Tumor Diagnosis

Macrophages, a type of white blood cell, defend the body by engulfing and digesting foreign particles, such as bacteria, viruses, and dead cells.

9 May 2023

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

A new publication in the May issue of Nature Aging by researchers from Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, demonstrates the power of artificial intelligence (AI) to discover novel senolytic compounds, a class of small molecules under intense study for their ability to suppress age-related processes such as fibrosis, inflammation and cancer.

8 May 2023

Eliminating or Blocking the Tiam1 Gene Prevents, Reverses Chronic Neuropathic Pain

Neuropathy is a type of chronic pain triggered by nerve injury or certain diseases. It affects millions of people worldwide, significantly deteriorating their quality of life.

5 May 2023

Study Reveals an Immunological Strategy to Overcome Microbiome-Related Immunotherapy Resistance

Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.

4 May 2023

Multi-Angled Approach of Identifying Dual-Purpose Therapeutic Targets Implicated in Aging, Glioblastoma

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 8, entitled, "Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform."

3 May 2023

PSG® Introduces New Biotech Brand

PSG®, a global pump, metering and dispensing-solution expert and an operating company within Dover Corporation, is proud to announce the creation and launch of its new PSG® Biotech brand.

3 May 2023

The Pivotal Role of Combinatorial CRISPR Gene Editing in the Elimination of HIV-1 Infection

Recent research from Temple University’s Lewis Katz School of Medicine and the University of Nebraska Medical Center demonstrates that gene-editing therapy aimed at two targets - HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that aids the virus getting into cells—can effectively eliminate HIV infection.

2 May 2023

New Genome Editing Technology Achieves Precise Targeted Insertion of DNA Segments

A new genome editing technology was developed by GAO Caixia’s group from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS). This technology achieves successful and accurate targeted insertion of large DNA segments in plants.

26 Apr 2023

Antibacterial Biologic Agent Effective Against Staphylococcus Aureus Infections in Early Tests

Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.

25 Apr 2023

Efficacy News and Research

Novel Gene-Editing Strategy Harnesses Unusual Protective Ability to Eliminate HIV-1 Infection

Research Details the Food Safety Profile of Genetically Edited Allergen-Free Eggs

Gut Microbiota Interspecies Interactions may Impact the Efficacy of Antibiotics Against C. Difficile

Scientists Engineer the First CRISPR-Based Drug Candidate to Directly Target E. Coli

Attaching Microbubbles to Macrophages can Create Tracking Images for Tumor Diagnosis

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

Eliminating or Blocking the Tiam1 Gene Prevents, Reverses Chronic Neuropathic Pain

Study Reveals an Immunological Strategy to Overcome Microbiome-Related Immunotherapy Resistance

Multi-Angled Approach of Identifying Dual-Purpose Therapeutic Targets Implicated in Aging, Glioblastoma

PSG® Introduces New Biotech Brand

The Pivotal Role of Combinatorial CRISPR Gene Editing in the Elimination of HIV-1 Infection

New Genome Editing Technology Achieves Precise Targeted Insertion of DNA Segments

Antibacterial Biologic Agent Effective Against Staphylococcus Aureus Infections in Early Tests

Engineered Sustainable, Patient-Specific NPCs Could Help Treat Neurodegenerative Diseases

Understanding the Functioning of Opioid Receptors at Unprecedented Spatial Resolution

A Novel Mechanism Identified for Lower Energy Expenditure After Weight-Loss

New Type of Drug Could Offer a Solution to Tackle Multidrug-Resistant Bacteria

Novel 3D Bioink Induces Organ Regeneration

Optimized Genome-Editing Method Vastly Reduces Mutations

Specialized Diet Stimulates a Unique Form of Programmed Cell Death

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics